{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:30:00Z","timestamp":1791304200586,"version":"4.3.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sjogren\u2019s syndrome (SS) is a rare chronic autoimmune disease involving exocrine glands presenting with sicca syndrome, recurrent parotitis and other extraglandular stigmata. SS is well characterized in the adult population with classification criteria; however, primary SS presenting in childhood is poorly defined and rare in males. Recurrent parotitis is the most common presenting symptom in children with primary SS; however, clinical phenotype in children appears more variable than in adults. The lungs are a common extraglandular location for manifestations of primary SS. However, interstitial lung disease (ILD) is rare in children with primary SS. There are only four published reports of ILD associated with primary SS in female children. Here, we present a very rare case of primary SS in a pediatric male with pulmonary manifestations and review of the literature on ILD in childhood-onset primary SS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 14-year-old White male with a history of chronic severe asthma, recurrent parotitis and idiopathic intracranial hypertension was referred to pediatric rheumatology for evaluation of a positive ANA. In early childhood, he was diagnosed with persistent asthma recalcitrant to therapy. At age 8, he developed recurrent episodes of bilateral parotitis despite multiple treatments with sialoendoscopy. At age 14, respiratory symptoms significantly worsened prompting reevaluation. Lab workup was notable for positive ANA and Sjogren\u2019s Syndrome A and B antibodies. Pulmonary function tests showed only a mild obstructive process. Computed tomography of chest was significant for small airway disease, and lung biopsy was positive for mild interstitial lymphocytic inflammation presenting a conflicting picture for ILD. The constellation of findings led to the diagnosis of primary SS with associated pulmonary manifestations. He was treated with hydroxychloroquine, mycophenolate mofetil and oral corticosteroids with resolution of symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Primary SS is a rare disease in the pediatric population that is poorly characterized. This case is the very rare presentation of childhood-onset primary SS with pulmonary manifestations in a male patient. ILD associated with primary SS is also very rare with only four pediatric patients reported in the literature. Collaborative effort is needed to develop pediatric specific diagnostic and treatment guidelines in this rare condition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-022-00761-z","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T23:02:36Z","timestamp":1668639756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pulmonary manifestations of childhood-onset primary Sjogren\u2019s syndrome (SS) masquerading as reactive airways disease in a male patient and review of interstitial lung disease associated with SS"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0571-0357","authenticated-orcid":false,"given":"Adam","family":"Bartholomeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shean","family":"Aujla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryle","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Kerrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Riemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mileka","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"issue":"11","key":"761_CR1","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"761_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9\u201316.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"761_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/BOR.0b013e328363ed23","volume":"25","author":"SM Lieberman","year":"2013","unstructured":"Lieberman SM. Childhood Sj\u00f6gren syndrome: insights from adults and animal models. Curr Opin Rheumatol. 2013;25(5):651\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"761_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijporl.2017.07.019","volume":"101","author":"C Means","year":"2017","unstructured":"Means C, Aldape MA, King E. Pediatric primary Sj\u00f6gren syndrome presenting with bilateral ranulas: a case report and systematic review of the literature. Int J Pediatr Otorhinolaryngol. 2017;101:11\u20139.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"2","key":"761_CR5","first-page":"343","volume":"34","author":"N Yokogawa","year":"2016","unstructured":"Yokogawa N, Lieberman SM, Sherry DD, Vivino FB. Features of childhood Sj\u00f6gren's syndrome in comparison to adult Sj\u00f6gren's syndrome: considerations in establishing child-specific diagnostic criteria. Clin Exp Rheumatol. 2016;34(2):343\u201351.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"761_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11926-008-0026-5","volume":"10","author":"NG Singer","year":"2008","unstructured":"Singer NG, Tomanova-Soltys I, Lowe R. Sj\u00f6gren's syndrome in childhood. Curr Rheumatol Rep. 2008;10(2):147\u201355.","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"761_CR7","first-page":"1603","volume":"32","author":"KM Houghton","year":"2005","unstructured":"Houghton KM, Cabral DA, Petty RE, Tucker LB. Primary Sj\u00f6gren's syndrome in dizygotic adolescent twins: one case with lymphocytic interstitial pneumonia. J Rheumatol. 2005;32(8):1603\u20136.","journal-title":"J Rheumatol"},{"issue":"7","key":"761_CR8","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1093\/rheumatology\/keaa757","volume":"60","author":"ML Basiaga","year":"2021","unstructured":"Basiaga ML, Stern SM, Mehta JJ, Edens C, Randell RL, Pomorska A, et al. Childhood Sj\u00f6gren syndrome: features of an international cohort and application of the 2016 ACR\/EULAR classification criteria. Rheumatology (Oxford). 2021;60(7):3144\u201355.","journal-title":"Rheumatology (Oxford)"},{"issue":"140","key":"761_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S. Pulmonary manifestations of Sj\u00f6gren's syndrome. Eur Respir Rev. 2016;25(140):110\u201323.","journal-title":"Eur Respir Rev"},{"key":"761_CR10","doi-asserted-by":"publisher","first-page":"e3821","DOI":"10.1136\/bmj.e3821","volume":"344","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Bosch X. Primary Sjogren syndrome. BMJ. 2012;344:e3821.","journal-title":"BMJ."},{"key":"761_CR11","doi-asserted-by":"publisher","unstructured":"Wang C, Simpkin C, Vielkind M, Galambos C, Lin C, Liptzin DR, et al. Childhood-onset Sj\u00f6gren syndrome presenting as pulmonary hemorrhage. Pediatrics. 2021;148(2). https:\/\/doi.org\/10.1542\/peds.2020-042127.","DOI":"10.1542\/peds.2020-042127"},{"key":"761_CR12","doi-asserted-by":"publisher","first-page":"h6819","DOI":"10.1136\/bmj.h6819","volume":"352","author":"SC Mathai","year":"2016","unstructured":"Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:h6819.","journal-title":"BMJ."},{"issue":"03","key":"761_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1378\/chest.70.3.354","volume":"70","author":"CV Strimlan","year":"1976","unstructured":"Strimlan CV, Rosenow EC, Divertie MB, Harrison EG. Pulmonary manifestations of Sj\u00f6gren's syndrome. Chest. 1976;70(03):354\u201361.","journal-title":"Chest."},{"issue":"9","key":"761_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/ard.59.9.709","volume":"59","author":"BK Davidson","year":"2000","unstructured":"Davidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sj\u00f6gren's syndrome. Ann Rheum Dis. 2000;59(9):709\u201312.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"761_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/BOR.0b013e328356813e","volume":"24","author":"S Dell","year":"2012","unstructured":"Dell S, Cernelc-Kohan M, Hagood JS. Diffuse and interstitial lung disease and childhood rheumatologic disorders. Curr Opin Rheumatol. 2012;24(5):530\u201340.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"761_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","volume":"171","author":"I Ito","year":"2005","unstructured":"Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"761_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5858\/2000-124-0071-GFCUOT","volume":"124","author":"A Kavanaugh","year":"2000","unstructured":"Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med. 2000;124(1):71\u201381.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"761_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/BF00451958","volume":"144","author":"C Vermylen","year":"1985","unstructured":"Vermylen C, Meurant A, No\u00ebl H, Claus D, Cornu G. Sj\u00f6gren\u2019s syndrome in a child. Eur J Pediatr. 1985;144(3):266\u20139.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"761_CR19","first-page":"1152","volume":"22","author":"JM Anaya","year":"1995","unstructured":"Anaya JM, Ogawa N, Talal N. Sj\u00f6gren's syndrome in childhood. J Rheumatol. 1995;22(6):1152\u20138.","journal-title":"J Rheumatol"},{"issue":"2","key":"761_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1442-200X.1997.tb03597.x","volume":"39","author":"M Tomiita","year":"1997","unstructured":"Tomiita M, Saito K, Kohno Y, Shimojo N, Fujikawa S, Niimi H. The clinical features of Sj\u00f6gren's syndrome in Japanese children. Acta Paediatr Jpn. 1997;39(2):268\u201372.","journal-title":"Acta Paediatr Jpn"},{"issue":"2","key":"761_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3899\/jrheum.200247","volume":"48","author":"AM Nilsson","year":"2021","unstructured":"Nilsson AM, Aaltonen HL, Olsson P, Persson HL, Hesselstrand R, Theander E, et al. Mixed airway and pulmonary parenchymal disease in patients with primary Sj\u00f6gren syndrome: a 6-year follow-up. J Rheumatol. 2021;48(2):232\u201340.","journal-title":"J Rheumatol"},{"issue":"25","key":"761_CR22","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006;354(25):2655\u201366.","journal-title":"N Engl J Med"},{"issue":"9","key":"761_CR23","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","volume":"4","author":"DP Tashkin","year":"2016","unstructured":"Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016;4(9):708\u201319.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"761_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00408-013-9499-8","volume":"191","author":"ST Panopoulos","year":"2013","unstructured":"Panopoulos ST, Bournia VK, Trakada G, Giavri I, Kostopoulos C, Sfikakis PP. Mycophenolate versus cyclophosphamide for progressive interstitial lung disease associated with systemic sclerosis: a 2-year case control study. Lung. 2013;191(5):483\u20139.","journal-title":"Lung."},{"issue":"5","key":"761_CR25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3899\/jrheum.121043","volume":"40","author":"A Fischer","year":"2013","unstructured":"Fischer A, Brown KK, Du Bois RM, Frankel SK, Cosgrove GP, Fernandez-Perez ER, et al. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol. 2013;40(5):640\u20136.","journal-title":"J Rheumatol"},{"key":"761_CR26","doi-asserted-by":"publisher","first-page":"143637","DOI":"10.1155\/2012\/143637","volume":"2012","author":"A Tzouvelekis","year":"2012","unstructured":"Tzouvelekis A, Galanopoulos N, Bouros E, Kolios G, Zacharis G, Ntolios P, et al. Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysis. Pulm Med. 2012;2012:143637.","journal-title":"Pulm Med"},{"issue":"8","key":"761_CR27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/1756-185X.12399","volume":"17","author":"N Yilmaz","year":"2014","unstructured":"Yilmaz N, Can M, Kocakaya D, Karakurt S, Yavuz S. Two-year experience with mycophenolate mofetil in patients with scleroderma lung disease: a case series. Int J Rheum Dis. 2014;17(8):923\u20138.","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"761_CR28","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.rmed.2013.02.015","volume":"107","author":"IC Mira-Avendano","year":"2013","unstructured":"Mira-Avendano IC, Parambil JG, Yadav R, Arrossi V, Xu M, Chapman JT, et al. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis\/dermatomyositis. Respir Med. 2013;107(6):890\u20136.","journal-title":"Respir Med"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00761-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00761-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00761-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T23:10:10Z","timestamp":1668640210000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00761-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["761"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00761-z","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"12 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Signed written consent for publication was obtained by patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}